| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |